Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
May 20, 2015Compelling Results Presented at EuroPCR 2015 Add to Growing Body of Evidence Supporting Performance and SafetyCompelling results presented at EuroPCR 2015 add to growing body of evidence supporting performance and safety
May 19, 2015Additional Data from EVOLVE II Pivotal Trial Demonstrate Safety and Performance in Patients with Diabetes at One YearAdditional data from EVOLVE II pivotal trial demonstrate safety and performance in patients with diabetes at one year
May 12, 2015Boston Scientific Corporation (NYSE: BSX) announced its completed public offering of senior notes
May 11, 2015Key data from 42 abstracts to include presentations on the WATCHMAN device and the EMBLEM S-ICD system.
- May 7, 2015
Boston Scientific Corporation (NYSE: BSX) announced its pricing of a public offering of senior notes
May 6, 2015Recognition From Shingo Institute is the Second in Two Years for a Company FacilityRecognition from Shingo Institute is the second in two years for a company facility
May 1, 2015CEO Mike Mahoney will outline company's unique opportunities to bring forward meaningful innovation
- Apr 30, 2015Customized Programs to Drive Operational and Care Pathway Improvements
Customized programs to drive operational and care pathway improvements
Apr 28, 2015"We achieved strong results in the first quarter and continue to build global momentum," said CEO Mike Mahoney
Apr 28, 2015MAJESTIC Trial Meets Performance Endpoint With Compelling ResultsMAJESTIC trial meets performance endpoint with compelling results